Identification of (-)-epicatechin metabolites and their metabolic fate in the rat

Drug Metabolism and Disposition

Volumn 27, Issue 2, 1999, Pages 309-316

  Okushio, Kazuo ^a   Suzuki, Masayuki ^a   Matsumoto, Natsuki ^a   Nanjo, Fumio ^a   Hara, Yukihiko ^a  

^a Mitsui Norin Co Ltd ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3' O METHYLEPICATECHIN; 3' O METHYLEPICATECHIN 5 O BETA GLUCURONIDE; 4' O METHYLEPICATECHIN; EPICATECHIN; EPICATECHIN 5 O BETA GLUCURONIDE; FLAVONOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BILE LEVEL; BLOOD LEVEL; CANCER; CONJUGATION; CONTROLLED STUDY; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISCHEMIC HEART DISEASE; LIVER HOMOGENATE; MALE; MASS SPECTROMETRY; METABOLISM; METABOLITE; METHYLATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STRUCTURE ANALYSIS; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; BILE; CATECHIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCURONATES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHYLATION; RATS; RATS, WISTAR; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT;

ANIMALIA;

EID: 0032965140     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Abe K, Inoue O and Yumioka E (1990) Biliary excretion of metabolites of baicalin and baicalein in rats. Chem Pharm Bull 38:208-211.
2. Crawford DL, Sinnhuber RO and Aft H (1961) The effect of methylation upon the antioxidant and chelation capacity of quercetin and dihydroquercetin in a lard substrate. J Food Sci 26:139-145.
3. Erben-Russ M, Bors W and Saran M (1987) Reactions of linoleic acid peroxyl radicals with phenolic antioxidants: A pulse radiolysis study. Int Radiat Biol 52:393-412.
4. Esterbauer H, Gebicki J, Puhl H and Jurgens G (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol Med 13:341-390.
5. Frankel EN, Kanner J, German JB, Parks E and Kinsella JE (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341:454-457.
6. 14C]-cyanidanol-3 in man following oral administration. Xenobiotica 13:279-286.
7. Hackett AM, Marsh IM, Barrow A and Griffiths LA (1979) The biliary excretion of flavanones in the rat. Xenobiotica 9:491-501.
8. Hackett AM, Shaw JC and Griffiths LA (1982) 3′-O-methyl-(+)-catechin glucuronide and 3′-O-methyl-(+)-catechin sulfate: New urinary metabolites of (+)-catechin in the rat and the marmoset. Experientia 38:538-540.
9. Hanasaki Y, Ogawa S and Fukui S (1994) The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radical Biol Med 16:845-850.
10. Haslam E (1966) Chemistry of Vegetable Tannins, Academic Press, London.
11. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB and Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The zutphen elderly study. Lancet 342:1007-1011.
12. Hertog MGL and Katan MB (1998) Quercetin in foods, cardiovascular disease, and cancer, in Flavonoids in Health and Disease (Rice-Evans C and Packer L eds) pp 483-522, Marcel Dekker, New York.
13. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedelikovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH and Katan MB (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155:381-386.
14. Hollman PCH and Katan MB (1998) Absorption, metabolism, and bioavailability of flavonoids, in Flavonoids in Health and Disease (Rice-Evans C and Packer L eds) pp 483-522, Marcel Dekker, New York.
15. Jovanovic SV, Steenken S, Simic MG and Hara Y (1998) Antioxidant properties of flavonoids: Reduction potentials and electron transfer reactions of flavonoid radicals, in Flavonoids in Health and Disease (Rice-Evans C and Packer L eds) pp 137-161, Marcel Dekker, New York.
16. Keli SO, Hertog MGL, Feskens EJM and Kromhout D (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med 156:637-642
17. Kondo K, Matsumoto A, Kurata H, Tanahasshi H, Koda H, Amachi T and Itakura H (1994) Inhibition of oxidation of low-density lipoprotein with red wine. Lancet 344:1152.
18. Leake DS (1998) Effects of flavonoids on the oxidation of low-density lipoproteins, in Flavonoids in Health and Disease (Rice-Evans C and Packer L eds) pp 253-276, Marcel Dekker. New York.
19. Lee MJ, Wang ZY, Li H, Chen L, Sun Y, Gobbo S, Balentine DA and Yang CS (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomerkers Prevent 4:393-399.
20. Letan A (1966) The relation of structure to antioxidant activity of quercetin and some of its derivatives: I. Primary activity. J Food Sci 31:518-523.
21. Macheix JJ, Fleuriet A and Billot J (1990) Fruit Phenolics, CRC Press, Boca Raton.
22. Nanjo F, Goto K, Seto R, Suzuki M, Sakai M and Hara Y (1996) Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radical Biol Med 21:895-902.
23. Nanjo F, Honda M, Okushio K, Matsumoto N, Ishigaki F, Ishigami T and Hara Y (1993) Effects of dietary tea catechins on α-tocopherol levels, lipid peroxidation, and erythrocyte deformability in rats fed on high palm oil and perilla oil diets. Biol Pharm Bull 16:1156-1159.
24. Okuda T, Kimura Y, Yoshida T, Hatano T, Okuda H and Arichi S (1983) Studies on the activity of tannins and related compounds from medicinal plants and drugs. I. Inhibitory effects on lipid peroxidation in mitochondria and microsomes of liver. Chem Pharm Bull 31:1625-1631.
25. Okushio K, Matsumoto N, Kohri T, Suzuki M, Nanjo F and Hara Y (1996) Absorption of tea catechins into rat portal vein. Biol Pharm Bull 19:326-329.
26. Piskula MK and Terao J (1998) Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J Nutr 128:1172-1178.
27. Robak J and Gryglewski RJ (1988) Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 37:837-841.
28. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP and Rice-Evans C (1995) Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322:339-346.
29. Serafini M, Ghiselli A and Ferro-Luzzi A (1994) Red wine, tea, and antioxidants. Lancet 344:626.
30. Serafini MS, Ghiselli A and Ferro-Luzzi A (1995) In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 50:28-32.
31. Shahidi F and Wanasundara PKJPD (1992) Phenolic antioxidants. Crit Rev Food Sci Nutr 32:67-103.
32. Shaw IC and Griffiths LA (1980) Identification of the major biliary metabolite of (+)-catechin in the rat. Xenobiotica 10:905-911.
33. 2. Free Radical Biol Med 11:1-8.
34. Steinberg D, Parthasarathy S, Carew TE, Khoo JC and Witzturn JL (1989) Modifications of low-density lipoprotein that increase its atherogenecity. N Engl J Med 320:915-923.
35. Terao J, Piskula M and Yao Q (1994) Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys 308:278-284.
36. Van Der Merwe PJ and Hundt HKL (1984) Metabolism of (+)-catechin and some of its C-6 and C-8 substituted derivatives in the isolated perfused pig liver. Xenobiotica 14:795-802.
37. Wermeille M, Turin E and Griffiths LA (1984) Identification of the major urinary metabolites of (+)-catechin and 3-O-methyl-(+)-catechin in man. Eur J Drug Metab Pharmacokinet 8:77-84.